Neogen Form 4: Chief Accounting Officer adds 18,416 shares, details options

Rhea-AI Filing Summary

Neogen Corp insider filing: John Patrick Moylan, identified as a director and Chief Accounting Officer, reported purchases on 08/15/2025. He acquired 18,416 shares of NEOG common stock at a price of $5.43 per share, bringing his total reported beneficial ownership to 31,371 shares. The filing also reports acquisition of derivative rights described as the right to buy 47,336 shares at a $5.43 exercise price, exercisable beginning 08/15/2025 and expiring 08/15/2035, with 47,336 underlying shares shown as beneficially owned following the transaction. The filing notes that options and restricted stock units vest in equal annual installments on each of the first three anniversary dates of the grants.

Positive

• Insider purchased additional shares (18,416 acquired) indicating increased executive ownership
• Clear vesting disclosure: options and RSUs vest in equal annual installments over three years
• Derivative position disclosed (right to buy 47,336 shares at $5.43, exercisable through 08/15/2035), providing transparency on potential future dilution

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider acquisition increases executive stake but appears to be a routine grant vesting and exercise-related transaction.

The Form 4 shows a single reporting person, John Patrick Moylan, acquiring 18,416 shares at $5.43 and reporting beneficial ownership of 31,371 shares. In addition, Moylan reports derivative rights to purchase 47,336 shares at a $5.43 exercise price with a 2035 expiration date. These entries are consistent with scheduled option/RSU vesting rather than an open-market opportunistic purchase. The magnitude of the derivative position relative to current ownership is material at the individual level but no company-level metrics (total outstanding shares or percent ownership) are provided, so investor impact cannot be quantified from this filing alone.

Corporate Governance Expert

TL;DR: Disclosure is timely and follows Section 16 reporting conventions; vesting schedule is explicitly stated.

The filing identifies the reporting person as both a director and an officer and discloses the vesting framework: options and RSUs vest in equal annual installments over the first three anniversaries. The presence of an attorney-in-fact signature indicates the filing was executed by an authorized representative. There are no governance red flags disclosed in this Form 4; it documents a standard executive compensation realization and associated beneficial ownership change.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moylan John Patrick

(Last) (First) (Middle)

620 LESHER PLACE

(Street)

LANSING MI 48912

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		A		18,416(1)	A	$5.43	31,371	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$5.43	08/15/2025		A		47,336		(1)	08/15/2035	Common Stock	47,336	$0	47,336	D

Explanation of Responses:

1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

	Christopher Sefcheck (Attorney in Fact)	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did NEOG insider John Patrick Moylan report on Form 4?

He reported acquiring 18,416 shares of NEOG common stock on 08/15/2025 at a price of $5.43 per share.

How many NEOG shares does John Patrick Moylan beneficially own after the reported transaction?

The Form 4 reports 31,371 shares beneficially owned following the transaction.

What derivative securities did the filing disclose for NEOG (ticker: NEOG)?

The filing discloses a right to buy 47,336 shares with an exercise price of $5.43, exercisable starting 08/15/2025 and expiring 08/15/2035.

What is the vesting schedule described in the Form 4 for the options and RSUs?

The filing states options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants.

Who signed the Form 4 and when was it filed?

The Form 4 was signed by an attorney-in-fact, Christopher Sefcheck, on 08/19/2025.